IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.377
EU - Europa 11.455
AS - Asia 9.770
SA - Sud America 1.766
AF - Africa 221
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 21
Totale 45.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.102
PL - Polonia 3.940
CN - Cina 3.749
SG - Singapore 2.860
UA - Ucraina 2.107
BR - Brasile 1.488
DE - Germania 1.462
HK - Hong Kong 1.213
IT - Italia 1.101
FI - Finlandia 660
VN - Vietnam 603
GB - Regno Unito 591
RU - Federazione Russa 409
TR - Turchia 386
IE - Irlanda 370
IN - India 326
FR - Francia 220
CA - Canada 137
BD - Bangladesh 128
SE - Svezia 112
CZ - Repubblica Ceca 101
ES - Italia 96
ZA - Sudafrica 92
ID - Indonesia 89
AR - Argentina 88
MX - Messico 79
NL - Olanda 77
JP - Giappone 74
EC - Ecuador 58
IQ - Iraq 48
IR - Iran 42
AT - Austria 41
BE - Belgio 41
PK - Pakistan 41
MA - Marocco 38
CO - Colombia 37
VE - Venezuela 31
SA - Arabia Saudita 23
AU - Australia 22
KE - Kenya 22
CL - Cile 21
EU - Europa 19
MU - Mauritius 19
PE - Perù 19
CH - Svizzera 18
LT - Lituania 18
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
AZ - Azerbaigian 16
JM - Giamaica 16
IL - Israele 15
PY - Paraguay 14
JO - Giordania 13
KR - Corea 13
KZ - Kazakistan 13
PA - Panama 13
PH - Filippine 13
EG - Egitto 12
TH - Thailandia 11
TN - Tunisia 11
RO - Romania 10
DZ - Algeria 9
KG - Kirghizistan 8
LV - Lettonia 8
BG - Bulgaria 7
CU - Cuba 7
DK - Danimarca 7
ET - Etiopia 7
LB - Libano 7
LK - Sri Lanka 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
TW - Taiwan 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
GE - Georgia 6
GR - Grecia 6
MY - Malesia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
AL - Albania 5
HR - Croazia 5
HU - Ungheria 5
NO - Norvegia 5
BY - Bielorussia 4
EE - Estonia 4
SN - Senegal 4
UY - Uruguay 4
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
GD - Grenada 2
HN - Honduras 2
IS - Islanda 2
LU - Lussemburgo 2
OM - Oman 2
SV - El Salvador 2
Totale 45.617
Salva come PNG Salva come JPEG
Città #
Warsaw 3.931
Fairfield 3.026
Woodbridge 2.187
Ashburn 1.918
Jacksonville 1.580
Houston 1.502
Singapore 1.221
Hong Kong 1.201
Ann Arbor 1.179
Cambridge 1.173
Seattle 1.098
Wilmington 1.062
Beijing 878
Chandler 798
Princeton 669
Nanjing 581
New York 460
Los Angeles 397
Brescia 381
Dublin 366
Dearborn 337
Dallas 319
Helsinki 308
Istanbul 302
Munich 221
Dong Ket 181
Nanchang 180
Ho Chi Minh City 170
San Francisco 161
Moscow 160
Buffalo 158
Shenyang 151
Des Moines 149
São Paulo 146
Hebei 144
Jinan 142
The Dalles 142
Changsha 136
San Diego 132
Shanghai 125
Milan 122
Chicago 110
Lancaster 104
Jiaxing 101
Tianjin 101
Redondo Beach 96
London 89
Santa Clara 89
Hanoi 87
Boardman 77
Kunming 73
Tokyo 69
Turku 69
Phoenix 66
Brno 64
Brooklyn 63
Hangzhou 63
Jakarta 63
San Mateo 61
Madrid 54
Verona 53
Guangzhou 48
Haikou 48
Johannesburg 48
Rome 45
Toronto 45
Augusta 43
Ningbo 43
Zhengzhou 43
Lanzhou 42
Rio de Janeiro 42
Boston 39
Nuremberg 38
Stockholm 37
Chennai 36
Belo Horizonte 35
Brussels 35
Kocaeli 35
Leawood 33
Orem 33
Washington 33
Montreal 32
Porto Alegre 32
Charlotte 31
Amsterdam 29
Fuzhou 29
Denver 28
Taizhou 28
Atlanta 27
Changchun 26
Mexico City 26
Olomouc 26
Curitiba 25
Kilburn 25
Ardabil 24
Brasília 24
Hefei 24
Norwalk 24
Poplar 24
Dhaka 23
Totale 32.354
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 318
The nanostructured secretome 315
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 314
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 294
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 294
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 294
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 286
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 279
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 275
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 274
Claudin3 is localized outside the tight junctions in human carcinomas 271
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 268
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 267
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 263
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 263
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 261
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 258
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 258
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 257
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 256
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 256
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 254
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 250
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 250
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 249
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 247
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 246
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 244
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 239
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 239
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 237
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 237
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 233
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 230
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 227
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 221
Zebrafish disease models in hematology: Highlights on biological and translational impact 210
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 205
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 205
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 201
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 200
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 199
Long pentraxin-3 follows and modulates bladder cancer progression 196
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 195
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 195
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 195
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 194
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 192
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 191
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 191
The zebrafish/tumor xenograft angiogenesis assay. 190
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 189
Anti-angiogenic activity of the purine analog 6-thioguanine. 188
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 185
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 184
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 182
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 182
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 182
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 180
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 179
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 178
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 177
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 175
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 174
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 172
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 172
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 172
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 169
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 168
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 167
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 167
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 165
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 165
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 165
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 163
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 163
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 163
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 162
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 161
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 161
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 161
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 160
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 160
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 159
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 159
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 158
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 157
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 157
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 157
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 156
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 156
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 155
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 155
Beta-Galactosylceramidase deficiency: neurovascular implications 154
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 154
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 154
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 153
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 153
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 153
Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications 152
Totale 20.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.063
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.258 0 0 0 0 324 618 262 687 758 527 702 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20256.143 86 57 40 861 652 574 516 250 708 468 1.139 792
2025/20266.844 1.327 1.675 1.078 1.838 926 0 0 0 0 0 0 0
Totale 46.386